Do GLP-1 drugs reduce inflammation?

In a 2025 study of nearly a million people with diabetes, those who took GLP-1 drugs had a reduction of 10% to 20% in heart failure, cardiac arrest, lung failure and pneumonia, and dementia, compared with people who took other diabetes medications.